For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Cardiac asthma - Independent medicine & health information for consumers & professionals Cardiac asthma
Show health professional infoLatest independent information about cardiac asthma, including medicines and non-drug treatments, written and reviewed by experts in Australia.
Cardiac asthma is also known as congestive heart failure, CHF, chronic heart failure, heart failure or chronic cardiac failure.
| Filter by audience: | |
|---|---|
| All | |
| Consumer | |
| Health professional | |
| Researchers & evaluators | |
| Members & stakeholders | |
| Other | |
| Title | Description | Type | Audience  |
Date* |
|---|---|---|---|---|
Angiotensin II receptor antagonists: unrestricted PBS listing |
Reviews new unrestricted PBS listing of candesartan, eprosartan, irbesartan, and telmisartan for hypertension, heart failure, and diabetic nephropathy. |
Professional publication - NPS RADAR - Review | Health Professionals | 2005-08-01 00:00:00 |
Carvedilol (Dilatrend) titration pack for heart failure |
Reviews PBS listing for a new titration pack size of carvedilol for heart failure. Includes discussion of titration packs and their use, and warnings about abrupt withdrawal of beta blockers. |
Professional publication - NPS RADAR - Review | Health Professionals | 2004-08-01 00:00:00 |
Case study 17 report: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study report | Health Professionals | 2001-10-01 00:00:00 |
Case study 17: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
Case study 34 report: Management of heart failure |
Elderly patient with recently diagnosed heart failure, IHD and occasional angina. Medications include frusemide and lisinopril (dose recently increased). Repeat serum biochemistry shows elevated creatinine and potassium. |
Professional activity - Case study report | Health Professionals | 2004-12-01 00:00:00 |
Case study 34: Management of heart failure |
Elderly patient with recently diagnosed heart failure, IHD and occasional angina. Medications include frusemide and lisinopril (dose recently increased). Repeat serum biochemistry shows elevated creatinine and potassium. |
Professional activity - Case study | Health Professionals | 2004-12-03 00:00:00 |
Case study 40 report: Assessing new evidence |
Elderly patient presents for whom you consider prescribing an angiotensin II receptor antagonist for his recently diagnosed heart failure. |
Professional activity - Case study report | Health Professionals | 2006-02-01 00:00:00 |
Case study 40: Assessing new evidence |
Elderly patient presents for whom you consider prescribing an angiotensin II receptor antagonist for his recently diagnosed heart failure. |
Professional activity - Case study | Health Professionals | 2005-11-01 00:00:00 |
Case study 52 report: Optimising chronic heart failure therapy |
Patient diagnosed with systolic heart failure presents with increased breathlessness. Examines optimal target medications. |
Professional activity - Case study report | Health Professionals | 2008-06-01 00:00:00 |
Case study 52: Optimising chronic heart failure therapy |
Patient diagnosed with systolic heart failure presents with increased breathlessness. Examines optimal target medications. |
Professional activity - Case study | Health Professionals | 2008-04-01 00:00:00 |
Case study 71: Heart failure |
Patient diagnosed with systolic heart failure presents with increased breathlessness. Examines optimal medicine regimens.. |
Professional activity - Case study | Health Professionals | 2011-10-04 00:00:00 |
Case study 8 report: Heart failure |
Elderly patient presents with increasing shortness of breath. Diagnosis of systolic heart failure is diagnosed and you decide to initiate an ACE inhibitor. |
Professional activity - Case study report | Health Professionals | 2000-04-01 00:00:00 |
Case study 8: Heart failure |
Elderly patient presents with increasing shortness of breath. Diagnosis of systolic heart failure is diagnosed and you decide to initiate an ACE inhibitor. |
Professional activity - Case study | Health Professionals | 2000-04-01 00:00:00 |
Case study 9 report: COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with recurrence of joint symptoms which were previously well controlled with paracetamol. |
Professional activity - Case study report | Health Professionals | 2000-07-01 00:00:00 |
Case study PH10 report: For pharmacists. Management of heart failure |
Elderly patient with recently diagnosed heart failure, IHD and occasional angina. Medications include frusemide and lisinopril (dose recently increased). Repeat serum biochemistry shows elevated creatinine and potassium. |
Professional activity - Case study report | Health Professionals | 2005-02-01 00:00:00 |
Case study PH10: For pharmacists. Management of heart failure |
Elderly patient with recently diagnosed heart failure, IHD and occasional angina. Medications include frusemide and lisinopril (dose recently increased). Repeat serum biochemistry shows elevated creatinine and potassium. |
Professional activity - Case study | Health Professionals | 2004-12-03 00:00:00 |
Case study PH4 report: For pharmacists. COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. |
Professional activity - Case study report | Health Professionals | 2002-02-01 00:00:00 |
Case study PH4: For pharmacists. COX-2 selective NSAIDs |
Patient with osteoarthritis, mild reflux and heart failure presents with increased joint pain previously well controlled with paracetamol. He asks about the new drug for arthritis. |
Professional activity - Case study | Health Professionals | 2001-10-01 00:00:00 |
Clinical e-Audit: an effective quality improvement activity to optimise treatment of ischaemic heart disease (IHD) in general practice. |
Clinical e-Audit aims to implement changes to practice and improve the treatment of patients with ischaemic heart disease (IHD) by general practitioners. ORiordan S, Lewis B, Parsons H, Mackson J, Reeve J. General Practice and Primary Health Care Research Conference. 4-6 June 2008. Hobart, Australia |
Event - Conference poster | Health Professionals,Research & Evaluation community | 2008-06-06 00:00:00 |
Eplerenone (Inspra) for use after acute myocardial infarction complicated by heart failure |
Reviews use of eplerenone for heart failure after acute myocardial infarction. Discusses the risk of hyperkalaemia and sex-hormone-related adverse effects. |
Professional publication - NPS RADAR - Review | Health Professionals | 2006-04-01 00:00:00 |
Articles on drugs for heart failure from NPS RADAR |
Get independent, accurate, evidence-based info on heart failure. Written for doctors, pharmacists & other health professionals. |
Topic overview | Health Professionals | 2009-10-28 00:00:00 |
Heart failure Arabic |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Arabic. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Chinese simplified |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into simplified Chinese. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Chinese traditional |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into traditional Chinese. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Croatian |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Croatian. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure English |
A brochure produced by the Heart Foundation on living well with chronic heart failure. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Greek |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Greek. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Italian |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Italian. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Korean |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Korean. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Macedonian |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Macedonian. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Maltese |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Maltese. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Polish |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Polish. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Portuguese |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Portuguese. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Russian |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Russian. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Serbian |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Serbian. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Spanish |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Spanish. |
Professional tool - Patient leaflet | Consumers,Health Professionals | 2009-06-01 00:00:00 |
Heart failure Turkish |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Turkish. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Heart failure Vietnamese |
A brochure produced by the Heart Foundation on living well with chronic heart failure translated into Vietnamese. |
Professional tool - Patient leaflet | Health Professionals,Consumers | 2009-06-01 00:00:00 |
Indicators of Quality Prescribing: 15 |
Indicators of Quality Prescribing: Indicator 15 Heart Failure and ACE Inhibitors. This indicator asks practices what percentage of patients with systolic heart failure are not currently prescribed an ACE inhibitor or angiotensin II-receptor antagonist. |
Professional tool - Indicators of quality prescribing | Health Professionals | 2006-02-01 00:00:00 |
Metoprolol succinate controlled-release (Toprol-XL) for heart failure |
Reviews use of controlled-release metoprolol succinate for heart failure, including diagnostic grading, titration guidelines, and comparison with other beta-blockers. |
Professional publication - NPS RADAR - Review | Health Professionals | 2004-05-01 00:00:00 |
Step-wise heart failure management |
This NPS News focuses on ACE inhibitors and beta-blockers and the barriers to better management of heart failure. Case study examines drug treatments. |
Professional publication - NPS News | Health Professionals | 2004-10-01 00:00:00 |
Chronic heart failure - early detection, drug therapy and patient support |
Highlights the importance of early detection and patient support to maximise the benefits of drug therapies at all stages of chronic heart failure. |
Professional publication - NPS News | Health Professionals | 2008-04-01 00:00:00 |
Systolic heart failure - improving treatment |
Outlines ways to improve treatment of systolic heart failure. Angiotensin-converting enzyme (ACE) inhibitors and heart failure specific beta blockers can reduce morbidity and mortality in people with systolic heart failure. |
Professional publication - NPS News | Health Professionals | 2011-10-04 00:00:00 |
NPS Prescribing Practice Review 28: Improving outcomes for heart failure patients |
Information on diagnosing heart failure and managing associated risk factors, along with the use of ACE inhibitors, diuretics, beta-blockers and non-drug interventions as treatment. |
Professional publication - Prescribing Practice Review | Health Professionals | 2004-11-09 00:00:00 |
Outcomes in chronic heart failure |
Highlights the importance of early detection, drug therapy and patient support for improving outcomes for people with chronic heart failure |
Professional publication - Prescribing Practice Review | Health Professionals | 2008-05-01 00:00:00 |
Heart failure - improving treatment |
Information on diagnosing heart failure and managing associated risk factors, along with the use of ACE inhibitors, diuretics, beta-blockers and non-drug interventions as treatment. |
Professional publication - Prescribing Practice Review | Health Professionals | 2011-11-01 00:00:00 |
NPS Prescribing Practice Review 8: Medication review for your patients with heart failure |
Information on how to take a medication history and determine if a patient is on all appropriate medications to optimise management of their heart failure. |
Professional publication - Prescribing Practice Review | Health Professionals | 2000-05-01 00:00:00 |
Prescribing data in general practice demonstration project: A pilot evaluation, Poster NMS 2010 |
The Prescribing Data in General Practice Demonstration (PDGPD) project used a data extraction tool to assist GP's identify quality prescribing practices. Elliott J, Sutherland K, Mohan S, Grunseit A, Williamson M, Parsons H. National Medicine Symposium, 26-28 May 2010, Melbourne, Australia |
Event - Conference poster | Health Professionals,Research & Evaluation community | 2010-05-28 00:00:00 |
NPS Prescribing Practice Review 28: Improving outcomes for heart failure patients |
Information on diagnosing heart failure and managing associated risk factors, along with the use of ACE inhibitors, diuretics, beta-blockers and non-drug interventions as treatment. |
Professional publication - Prescribing Practice Review | Health Professionals | 2004-11-09 00:00:00 |
Rosiglitazone and cardiovascular risk |
Fact sheet on a meta-analysis of clinical trials which reported that rosiglitazone is responsible for a small increase in the risk of myocardial infarction. |
Professional publication - NPS factsheet | Health Professionals | 2007-07-25 00:00:00 |
Information on this website is published by NPS — an independent, evidence based, not-for-profit organisation funded by the Australian Government Department of Health and Ageing.
NPS develops its information under the guidance of experts in their field, editorial panels, expert reviewers and consumers. Find out more about how we develop our content.
Date published: 2010-12-17 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
